Cardiac & Antihypertensive

Telmisartan + Metoprolol SuccinateThird Party Manufacturing in India

Looking to get Telmisartan + Metoprolol Succinate manufactured under your brand? Our WHO-GMP certified partner facilities support PCD franchise partners and global export opportunities structured across 25+ countries.

WHO-GMP Certified
Export Ready
PCD Franchise Available
CAS Number
144701-48-4
Drug Class
ARB and Beta-blocker combination
Molecular Formula
Combination product (C₃₃H₃₀N₄O₂ / (C₁₅H₂₅NO₃)₂ · C₄H₄O₄)
Molecular Weight
Combination product
Grade Standards
IP, BP, USP
Therapeutic Category
Cardiac & Antihypertensive
MOQ
30,000 tablets per batch
Dosage Forms
Extended Release Tablet

Mechanism of Action

Telmisartan + Metoprolol Succinate works through a dual mechanism combining an angiotensin receptor blocker with a selective beta-1 adrenergic antagonist. Telmisartan blocks AT1 receptors to cause systemic vasodilation, while Metoprolol Succinate acts on cardiac beta-1 receptors to decrease heart rate, myocardial contractility, and cardiac output. It targets these physiological paths to help the body lower arterial blood pressure while reducing myocardial oxygen demand. Unlike short-acting formulations, the extended-release succinate matrix ensures a steady therapeutic release. It is highly effective and well-tolerated.

Therapeutic Uses & Indications

Therapeutic Uses

  • Hypertension with CAD: Manages elevated blood pressure while protecting the myocardium in patients with coronary artery disease.
  • Post-Myocardial Infarction Care: Regulates cardiac workload and blood pressure following acute coronary syndrome events.
  • Chronic Stable Angina: Aids in reducing the frequency and severity of angina attacks by minimizing heart rate variations.

Why Manufacturers Choose Telmisartan + Metoprolol Succinate

Telmisartan + Metoprolol Succinate third party manufacturing in India requires sophisticated modified-release formulation capabilities. Sustaining the release of Metoprolol while maintaining the stability of hygroscopic Telmisartan demands specialized pelletization or matrix-embedding techniques. Our partner facilities possess advanced extended-release coating and multi-particulate compression technologies that adhere to strict WHO-GMP guidelines, ensuring uniform 24-hour pharmacokinetic profiles.

Dosage Forms We Manufacture

Extended Release Tablet
40mg + 50mg

Frequently Asked Questions

What is the minimum order quantity for Telmisartan + Metoprolol Succinate?
Minimum order quantity for Telmisartan + Metoprolol Succinate is 30,000 tablets per batch. Please contact us for bulk pricing and custom quantities.
What dosage forms of Telmisartan + Metoprolol Succinate can you manufacture?
We manufacture Telmisartan + Metoprolol Succinate as: Extended Release Tablet (40mg + 50mg).
Are your manufacturing facilities WHO-GMP certified?
Yes. Celesta Healthcare works exclusively with WHO-GMP certified partner production facilities. All manufacturing batches are subject to strict quality control and documentation.
Can you manufacture Telmisartan + Metoprolol Succinate for export?
Yes. We provide export-ready Telmisartan + Metoprolol Succinate formulations structured across 25+ countries. We provide full export documentation including Certificate of Analysis (CoA), Certificate of Origin, and regulatory dossiers on request.
What grade standards do you follow for Telmisartan + Metoprolol Succinate?
We manufacture Telmisartan + Metoprolol Succinate to IP, BP, USP pharmacopoeial standards.
Third Party Manufacturing

Get Telmisartan + Metoprolol Succinate made under your brand

  • WHO-GMP certified facilities
  • Quote within 24 hours
  • MOQ from 30,000 tablets per batch
Get a Manufacturing QuoteWhatsApp Us Now

+91 9689237122 · replies within hours

Our Manufacturing Capabilities

  • WHO-GMP Certified Partner Plants
  • 25+ years of pharma industry experience
  • PCD Franchise with monopoly rights
  • Export support across 25+ countries
  • Small batch to commercial scale
  • Custom formulation development

Packaging Options

Moisture-barrier Alu-Alu blister packaging designed to maintain controlled-release matrix stability.

Start Manufacturing Telmisartan + Metoprolol Succinate Today

Celesta Healthcare provides WHO-GMP certified third-party manufacturing for Telmisartan + Metoprolol Succinate across all dosage forms. PCD franchise and export orders welcome.

Need something? Chat with us!